Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains

Documenti analoghi

• Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins.
  di: Sanderson, S, et al.
  Pubblicazione: (1995)
• Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II
  di: Rehm, Kristina E, et al.
  Pubblicazione: (2009)
• Exogenous peptides compete for the presentation of endogenous antigens to major histocompatibility complex class II-restricted T cells
  Pubblicazione: (1991)
• Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
  di: Wieczorek, Marek, et al.
  Pubblicazione: (2017)
• Second Class Minors: Molecular Identification of the Autosomal H46 Histocompatibility Locus as a Peptide Presented by Major Histocompatibility Complex Class II Molecules
  di: Sahara, Hiroeki, et al.
  Pubblicazione: (2003)